SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
Tonix Pharmaceuticals Holding Corp.
@TNXP_InsiderForm 4 Filing: SAENGER BRADLEY Acquires $15,858.042 of $TNXP
INSIDER TRANSACTION
⚡ MATERIALITY: 3/10
corporate issuer
Tonix Pharmaceuticals Holding Corp.
Ticker: $TNXP
Transaction Value
$15,858.042
Price/Share: $10.91
transaction date
2026-06-30
Shares: 1,453
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, SAENGER BRADLEY, holds the title of Chief Financial Officer at Tonix Pharmaceuticals Holding Corp..
On 2026-06-30, the insider transacted 1,453 shares.The shares were transacted at a weighted average price of $10.91 per share, resulting in a total market-relevant value of $15,858.042.
Executive Summary Summary
SAENGER BRADLEY (Chief Financial Officer) transacted $16K of $TNXP
Post-Transaction Position: 2,154 shares
SEC Accession No: 0001493152-26-032615 (CIK: 1668150)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.